Several drug firms have agreed on a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunization alliance that is overseeing the deal.
Go to Source
Drugmakers agree on landmark vaccines deal for poor
This entry was posted in Montreal City. Bookmark the permalink.
